title: Methylphenidate. An update on extended-release formulations.
abstract: Methylphenidate remains the mainstay of pharmacological management in attention deficit hyperactivity disorder (ADHD). Despite having been available for over half a century, methylphenidates original formulation has been modified with the main purpose of extending its duration of action. This article will present a brief review of how these new formulations vary and how these should be selected, considering the evidence available on their effectiveness and on the individual needs of the patient.
authors.affiliation: The School of Pharmacy, The University of Auckland, Private Bag 92019, Auckland, New Zealand. Tel. +64 (9) 3737599 Ext. 82225. Fax. +64 (9) 3677192. E-mail: m.zolezzi@auckland.ac.nz.
authors.forename: Monica
authors.initials: M
authors.lastname: Zolezzi